Sort
48,018 grants matching “immunotherapy”
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,387,573Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · AI
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2002 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2004 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2003 · DK
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,386,496Julie R Park · Seattle Children'S Hospital · U01 · FY2020 · TR
Cellular Interactions with Thrombospondin
$1,386,100David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Deciphering the crosstalk between bacteria and their mammalian hosts
$1,385,900Aaron Thomas Whiteley · University Of Colorado · DP2 · FY2022 · AT
Mapping and Therapeutic Hijacking of Lysosomal Transport
$1,385,226Steven Banik · Stanford University · DP2 · FY2023 · GM
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,384,924Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cellular Vaccines for Cancer Therapy
$1,384,883University Of Michigan At Ann Arbor · P01 · FY2001 · CA
Novel Approaches to Stem Cell Transplantation
$1,384,530Duke University · P01 · FY2004 · CA
Regulation of epithelial cell fate decisions in tissue homeostasis and cancer
$1,383,497Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Novel Approaches to Stem Cell Transplantation
$1,382,672Duke University · P01 · FY2003 · CA
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,381,473Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2011 · AI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$1,381,210Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$1,380,842University Of Texas Sw Med Ctr/Dallas · U01 · FY2003 · AI
A Vaccine for Schistosomiasis, "SchistoShield"
$1,380,664Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2017 · AI
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$1,380,481Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Microparticle Therapy for Cerebral Amyloid Angiopathy
$1,380,461Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2020 · AG
IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA
$1,380,346Truman R. Brown · Columbia University Health Sciences · R01 · FY2007 · CA
Building on the success of the adoptive immunotherapy of cancer
$1,380,074Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Coordinating center for the NCI small cell lung cancer research consortium
$1,379,839Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2025 · CA
Novel Strategies for Brain Tumor Therapy
$1,379,728University Of Pittsburgh At Pittsburgh · P01 · FY2004 · NS
CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer
$1,379,442Christopher Barron · Embiosys Inc. · R44 · FY2025 · CA
SPORE IN OVARIAN CANCER
$1,378,723University Of Alabama At Birmingham · P50 · FY2000 · CA